Skip to main content

Table 6 Baseline characteristics of patients with or without DVT in patients receiving THA

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

 

DVT(+)

DVT(-)

P value

n = 109

n = 759

Age, ≧75 years

43 (39.4%)

189 (24.9%)

0.001

Female gender

102 (93.6%)

638 (84.1%)

0.009

e-GFR, <60 mL/min per 1.73 m2

17 (15.6%)

102 (13.5%)

0.547

Body mass index, ≧30 kg/m2

7 (6.4%)

49 (6.5%)

0.981

General anesthesia

83 (76.1%)

666 (87.7%)

0.001

Operation time, ≧120 minutes

42 (38.5%)

353 (46.5%)

0.118

Use of foot pump

83 (76.1%)

586 (77.2%)

0.806

Use of elastic stocking

95 (87.2%)

697 (91.8%)

0.106

Medications

   

  Unfractionated heparin

5 (4.6%)

27 (3.6%)

0.374

  Enoxaparin

17 (15.6%)

131 (17.3%)

0.666

  Fondaparinux

17 (15.6%)

244 (32.1%)

<0.0001

  Others

8 (7.3%)

36 (4.7%)

0.248

  1. CI, confidence interval; DVT, deep vein thrombosis; e-GFR, estimated glomerular filtrating ratio; PE, pulmonary embolism; THA, total hip arthroplasty.